- Source: Levonorgestrel cyclopropylcarboxylate
Levonorgestrel cyclopropylcarboxylate (developmental code name HRP-003), or levonorgestrel 17β-cyclopropylcarboxylate, is a progestin and a progestogen ester which was studied for potential use as an injectable hormonal contraceptive but was never marketed. It was developed by the World Health Organization's Special Programme on Human Reproduction in the 1980s. Analogues of levonorgestrel cyclopropylcarboxylate include levonorgestrel cyclobutylcarboxylate (HRP-001) and levonorgestrel butanoate (HRP-002).
See also
List of progestogen esters § Esters of 19-nortestosterone derivatives
Progestogen-only injectable contraceptive
References
Kata Kunci Pencarian:
- Levonorgestrel cyclopropylcarboxylate
- Levonorgestrel cyclobutylcarboxylate
- Special Programme on Human Reproduction
- C25H32O3
- List of progestogen esters
- Gestodene
- Ulipristal acetate
- Desogestrel
- Progestogen-only injectable contraceptive
- Triamcinolone acetonide